The invention relates to the technical field of mRNA
vaccine research and development, and discloses a Tp0136
T cell epitope mRNA vaccine based on lipid
nanoparticle delivery and application of the Tp0136
T cell epitope mRNA vaccine in
syphilis prevention, the vaccine contains an mRNA sequence and an LNP
delivery system, the mRNA sequence contains a Tp0136T1
T cell epitope coding region (
amino acid L477-S486, optimized by codon), a Cap 1 structure, optimized UTR and poly (A) tails of 65-76
adenosine, and psi or m5C is used for replacing
trona; the LNP is prepared from SM-102, DSPC (Distearoyl Pyrrolidone),
cholesterol and DMG-PEG (Dimethyl Glycol-
Polyethylene Glycol) according to a
molar ratio of 50 The particle size of the vaccine is less than or equal to 150nm, PDIlt; 0.2, the
Zeta potential is-5 to-15 mV, and the encapsulation efficiency is greater than or equal to 93.47%. The preparation method comprises the steps of mRNA
design synthesis, mRNA-LNP preparation characterization and in-vitro expression
verification, through
intramuscular injection inoculation, strong Th1 type and CD8 + CTL immune response can be induced,
treponema pallidum load and
skin ulcer rate can be reduced, and the method can be used for
syphilis prevention.